Meyka Pro banner
Noevir Holdings Co., Ltd.

Noevir Holdings Co., Ltd. Fundamental Analysis (JPX: 4928.T)

4928.TJPX
Consumer DefensiveHousehold & Personal Products
¥4875.00
¥0.00(0.00%)
Japanese Market opens in NaNh NaNm

Noevir Holdings Co., Ltd. Fundamental Analysis (JPX: 4928.T)

Noevir Holdings Co., Ltd. (JPX: 4928.T) shows moderate financial fundamentals with a PE ratio of 21.10, profit margin of 12.59%, and ROE of 15.90%. The company generates $63.5B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position14.33%
Current Ratio4.80

Areas of Concern

PEG Ratio4.08
We analyze 4928.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 87.8/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B+
87.8/100

We analyze 4928.T's fundamental strength across five key dimensions:

Efficiency Score

Excellent

4928.T demonstrates superior asset utilization.

ROA > 10%
10.88%

Valuation Score

Moderate

4928.T shows balanced valuation metrics.

PE < 25
21.10
PEG Ratio < 2
4.08

Growth Score

Moderate

4928.T shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

4928.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
4.80

Profitability Score

Moderate

4928.T maintains healthy but balanced margins.

ROE > 15%
15.90%
Net Margin ≥ 15%
12.59%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 4928.T Expensive or Cheap?

P/E Ratio

4928.T trades at 21.10 times earnings. This indicates a fair valuation.

21.10

PEG Ratio

When adjusting for growth, 4928.T's PEG of 4.08 indicates potential overvaluation.

4.08

Price to Book

The market values Noevir Holdings Co., Ltd. at 3.31 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.31

EV/EBITDA

Enterprise value stands at 15.05 times EBITDA. This signals the market has high growth expectations.

15.05

How Well Does 4928.T Make Money?

Net Profit Margin

For every $100 in sales, Noevir Holdings Co., Ltd. keeps $12.59 as profit after all expenses.

12.59%

Operating Margin

Core operations generate 15.69 in profit for every $100 in revenue, before interest and taxes.

15.69%

ROE

Management delivers $15.90 in profit for every $100 of shareholder equity.

15.90%

ROA

Noevir Holdings Co., Ltd. generates $10.88 in profit for every $100 in assets, demonstrating efficient asset deployment.

10.88%

Following the Money - Real Cash Generation

Operating Cash Flow

Noevir Holdings Co., Ltd. generates limited operating cash flow of $2.12B, signaling weaker underlying cash strength.

$2.12B

Free Cash Flow

Noevir Holdings Co., Ltd. generates weak or negative free cash flow of $1.52B, restricting financial flexibility.

$1.52B

FCF Per Share

Each share generates $44.53 in free cash annually.

$44.53

FCF Yield

4928.T converts 0.90% of its market value into free cash.

0.90%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

21.10

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

4.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.31

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.66

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.01

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.80

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.16

vs 25 benchmark

ROA

Return on assets percentage

0.11

vs 25 benchmark

ROCE

Return on capital employed

0.16

vs 25 benchmark

How 4928.T Stacks Against Its Sector Peers

Metric4928.T ValueSector AveragePerformance
P/E Ratio21.1021.73 Neutral
ROE15.90%661.00% Weak
Net Margin12.59%-2335.00% (disorted) Strong
Debt/Equity0.010.81 Strong (Low Leverage)
Current Ratio4.802.28 Strong Liquidity
ROA10.88%313.00% Weak

4928.T outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Noevir Holdings Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Dividend, Low Volatility

EPS CAGR

N/A

Industry Style: Defensive, Dividend, Low Volatility

FCF CAGR

N/A

Industry Style: Defensive, Dividend, Low Volatility

Fundamental Analysis FAQ